About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Cd1d1tm1.1Boes
targeted mutation 1.1, Marianne Boes
MGI:4355877
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Cd1d1tm1.1Boes/Cd1d1tm1.1Boes involves: C57BL/6 MGI:4355883
cx2
 		Cd1d1tm1.1Boes/Cd1d1tm1.1Boes
Cd74tm1Doi/Cd74tm1Doi 		involves: 129S2/SvPas * C57BL/6 MGI:4355888


Genotype
MGI:4355883
hm1
Allelic
Composition		 Cd1d1tm1.1Boes/Cd1d1tm1.1Boes
Genetic
Background		 involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1.1Boes mutation (0 available); any Cd1d1 mutation (35 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
abnormal NK T cell morphology ( J:151699 )
• Valpha14 invariant NKT cell displaya bias in their Vbeta repertoire, with an overrepresentation of Vbeta7
• thymic Valpha14 invariant NKT cells significantly remain in the earlier stages of development compared to controls
• these cells have increased expression of immature markers such as Slamf1 and CD69
• thymic Valpha14 invariant NKT cells at all stages of development in the thymus display increased rates of apoptosis compared to controls
decreased NK T cell number ( J:151699 )
• Valpha14 invariant NKT cell numbers are reduced 60% in the thymus and 80% in the liver and spleen
abnormal NK T cell physiology ( J:151699 )
• Valpha14 invariant NKT cells have reduced expression of IL-2 and IL-4 when activated
• IFN-gamma secretion upon activation is similar to controls
abnormal dendritic cell antigen presentation ( J:151699 )
• dendritic cells loaded with alphaGal-Cer are defective in activating wild-type Valpha14 invariant NKT cells
decreased interleukin-2 secretion ( J:151699 )
• Valpha14 invariant NKT cells have reduced expression of IL-2 and IL-4 when activated
abnormal interleukin-4 secretion ( J:151699 )
• Valpha14 invariant NKT cells have reduced expression of IL-2 and IL-4 when activated

hematopoietic system
abnormal NK T cell morphology ( J:151699 )
• Valpha14 invariant NKT cell displaya bias in their Vbeta repertoire, with an overrepresentation of Vbeta7
• thymic Valpha14 invariant NKT cells significantly remain in the earlier stages of development compared to controls
• these cells have increased expression of immature markers such as Slamf1 and CD69
• thymic Valpha14 invariant NKT cells at all stages of development in the thymus display increased rates of apoptosis compared to controls
decreased NK T cell number ( J:151699 )
• Valpha14 invariant NKT cell numbers are reduced 60% in the thymus and 80% in the liver and spleen
abnormal NK T cell physiology ( J:151699 )
• Valpha14 invariant NKT cells have reduced expression of IL-2 and IL-4 when activated
• IFN-gamma secretion upon activation is similar to controls




Genotype
MGI:4355888
cx2
Allelic
Composition		 Cd1d1tm1.1Boes/Cd1d1tm1.1Boes
Cd74tm1Doi/Cd74tm1Doi
Genetic
Background		 involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1.1Boes mutation (0 available); any Cd1d1 mutation (35 available)
Cd74tm1Doi mutation (1 available); any Cd74 mutation (36 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
abnormal dendritic cell antigen presentation ( J:151699 )
• dendritic cells loaded with alphaGal-Cer are defective in activating wild-type Valpha14 invariant NKT cells




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
10/29/2024
MGI 6.24 		The Jackson Laboratory